Abstract:
The present invention relates to a method for screening bovine tuberculosis using an electronic nose, and more specifically, to a method for screening bovine tuberculosis using an electronic nose provided with a metal oxide sensor (MOS). According to the present invention, labor and costs are remarkably reduced by automatically screening serum infected with bovine tuberculosis and serum not infected with bovine tuberculosis with the electronic nose through a simple one-time sample injection process, and thereby rapidly screening a large number of cows with suspected bovine tuberculosis infection.
Abstract:
PURPOSE: A pharmaceutical composition for goat floppy kid syndrome treatment including bicarbonate is provided to apply the composition to goats in a large scale farm by orally applying to the goats. CONSTITUTION: A pharmaceutical composition for goat floppy kid syndrome treatment including bicarbonate comprises 5-95 weight% of bicarbonate and 5-95 weight% of pharmaceutically approved excipient. The pharmaceutical composition for the goat floppy kid syndrome treatment including bicarbonate comprises 5-94 weight% of bicarbonate, 5-90 weight% of pharmaceutically approved excipient, and 1-10 weight% of additive. The pharmaceutical composition for the goat floppy kid syndrome is orally applied to goats. [Reference numerals] (AA) Before injection; (BB) After 4-5 hours; (CC) After 9-12 hours; (DD) After 24-28 hours;
Abstract:
PURPOSE: A method for diagnosing cattle tuberculosis using intradermal diagnostic composition is provided to easily prepare a large amount of intradermal diagnostic composition and to ensure diagnosis accuracy. CONSTITUTION: An intradermal diagnostic composition for testing cattle tuberculosis contains recombinant proteins of Esat6, HspX, PhoS, MPB70, MPB64, MPB83, Ag85, and SahH. A method for diagnosing tuberculosis of mammal except for human is performed using the intradermal diagnostic composition containing the recombinant proteins. The recombinant protein is prepared by isolating from Mycobacterium bovis and performing PCR.
Abstract:
A bacteriolysis extract of Saccharomyces chevalieri is provided to increase the activation of neutrophil and enhance non-specific defense activity against the pathogenic bacteria. An immune enhancer, vaccine adjuvant, adjuvant treating agent or feed additive comprises bacteriolysis extract of Saccharomyces chevalieri as an active ingredient. A method for manufacturing a bacteriolysis extract of Saccharomyces chevalieri comprises: a step of culturing Saccharomyces chevalieri in media at 26°C for 72 hours; a step of centrifuging media and suspending in PBS; a step of adding dissolution agent and treating at room temperature for 2-3 days; a step of confirming the dissolution status with a microscope; a step of adjusting pH concentration to 6.5-7.2; and a step of drying and maintaining in a refrigerator.
Abstract:
An immune enhancer and vaccine adjuvant additive for animal, which contains Zygosaccharomyces bailii lysates and an auxiliary therapeutic agent are provided to enhance the activation of neutrophil and non-specific protection effect to attack inoculation. An immune enhancer, vaccine adjuvant additive, auxiliary therapeutic agent and feed additive comprises a Zygosaccharomyces bailii lysates. A method for manufacturing the Zygosaccharomyces bailii lysate comprises: a step of culturing the Zygosaccharomyces bailii in the media at 26‹C for 72 hours; a step of centrifuging the cultured media and suspending in phosphate buffered saline (PBS); a step of adding dissolution agent and stirring at room temperature for two to three days; a step of adjusting pH concentration to 6.5-7.2; and a step of drying and maintaining in a thermostatic chamber.
Abstract:
Provided is an immunostimulant using dandelion extract which improves a function of a nonspecific defense against pathogen and increases activity of animal immunocytes such as neutrophil and macrophages. An immunostimulant using dandelion extract comprises dandelion extract obtained by a hot water process as an active ingredient. A method for preparing the immunostimulant comprises a steps of extracting the dandelion extract at a temperature of 90~100°C by hot distilled water. The dandelion extract can be used independently or with additives which are generally used.
Abstract:
A plate agglutination tester and a method for measuring an immuno-reaction using the same are provided to decrease error of the result analysis in accordance with proficiency of a person performing diagnosis, show the degree of various immuno-reactions in an objective value and perform various statistical analyses, thereby being very useful for measuring the immuno-reaction. A plate agglutination tester consists of a transparent film and is characterized in that a section, which consists of a plurality of circles and where an antigen-antibody agglutination reaction occurs, is arranged and formed in horizontal and vertical directions on an upper side of the film. A method for measuring an immuno-reaction comprises the steps of: (a) mixing an antigen and an antibody specifically bound to the antigen with the plate agglutination tester to induce an agglutination reaction; (b) scanning the agglutination reaction induced plate agglutination tester and converting a scanning result into an image file; and (c) analyzing the obtained image file using a computer program capable of detecting fine agglutination reactants to numberize the intensity of the agglutination reaction. Further, the transparent film is an over head project film.
Abstract:
본 발명은 살모넬라 티피뮤리움(Salmonella typhimurium), 살모넬라 엠반다카(Salmonella mbandaka), 및 살모넬라 엔테라이티디스(Salmonella enteritidis)에서 추출한, 그룹특이성 및 민감성이 우수하고 항원성이 뛰어난 LPS(lipopolysaccharide)를 혼합하여 항원으로 사용하는 것을 특징으로 하는 동물의 살모넬라 감염항체 검사키트를 제공한다. 살모넬라 감염항체, 살모넬라 티피뮤리움, 살모넬라 엔테라이티디스, 살모넬라 엠반다카, 리포폴리사카라이드(LPS), ELISA, 검사키트
Abstract:
본 발명은 국내 유행 살모넬라균 혈청그룹인 그룹 B, C 및 D에 속하는 각각의 살모넬라균주의 세포외막단백질(OMP)을 면역항원으로 함유하는 동물 살모넬라 감염 예방용 혼합백신을 제공한다. 본 발명은 바람직하게는 상기 그룹 B에 속하는 살모넬라균으로는 살모넬라 티피뮤리움을, 그룹 C에 속하는 살모넬라균으로는 살모넬라 브렌더럽을, 및 그룹 D에 속하는 살모넬라균으로는 살모넬라 엔테라이티디스 균주가 선택되어지는 혼합백신을 제공한다.
Abstract:
본 발명은 국내 유행 살모넬라균 혈청그룹인 그룹 B, C 및 D에 속하는 각각의 살모넬라균주의 세포외막단백질(OMP)을 면역항원으로 함유하는 동물 살모넬라 감염 예방용 혼합백신을 제공한다. 본 발명은 바람직하게는 상기 그룹 B에 속하는 살모넬라균으로는 살모넬라 티피뮤리움을, 그룹 C에 속하는 살모넬라균으로는 살모넬라 브렌더럽을, 및 그룹 D에 속하는 살모넬라균으로는 살모넬라 엔테라이티디스 균주가 선택되어지는 혼합백신을 제공한다.